Achieving hepatitis C elimination in Europe - To treatment scale-up and beyond.

Hellard, M; Scott, N; Sacks-Davis, R; Pedrana, A

Hellard, M; Scott, N; Sacks-Davis, R; Pedrana, A.

Afiliação

Hellard M; Burnet Institute, Melbourne, VIC 3004, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC 3008, Australia; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, VIC 3004, Australia. Electronic address: margaret.hellard@bu
Scott N; Burnet Institute, Melbourne, VIC 3004, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC 3008, Australia.
Sacks-Davis R; Burnet Institute, Melbourne, VIC 3004, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3010.
Pedrana A; Burnet Institute, Melbourne, VIC 3004, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC 3008, Australia.

J Hepatol ; 68(3): 383-385, 2018 03.

Article em En | MEDLINE | ID: mdl-29233629

Assuntos

Hepatite C; Europa (Continente); Hepacivirus; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Hepatol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google